Biocon founder Kiran Mazumdar-Shaw has reportedly named her niece, Claire Mazumdar, as the company’s successor. Claire, founder and CEO of Bicara Therapeutics, brings advanced qualifications and prior industry experience. The announcement also comes amid broader structural and leadership changes across Biocon group firms as it pushes biosimilars and deeper artificial intelligence integration.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
